Agnes Bonifacius

636 total citations
18 papers, 117 citations indexed

About

Agnes Bonifacius is a scholar working on Oncology, Epidemiology and Immunology. According to data from OpenAlex, Agnes Bonifacius has authored 18 papers receiving a total of 117 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Epidemiology and 6 papers in Immunology. Recurrent topics in Agnes Bonifacius's work include Cytomegalovirus and herpesvirus research (6 papers), Immune Cell Function and Interaction (5 papers) and Polyomavirus and related diseases (5 papers). Agnes Bonifacius is often cited by papers focused on Cytomegalovirus and herpesvirus research (6 papers), Immune Cell Function and Interaction (5 papers) and Polyomavirus and related diseases (5 papers). Agnes Bonifacius collaborates with scholars based in Germany, Slovakia and Canada. Agnes Bonifacius's co-authors include Britta Eiz‐Vesper, Rainer Blasczyk, Britta Maecker‐Kolhoff, Jochen Huehn, Anna Christina Dragon, Sabine Tischer‐Zimmermann, Christina Kloth, Katharina Zimmermann, Thomas Nerreter and Axel Schambach and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Cellular and Molecular Life Sciences.

In The Last Decade

Agnes Bonifacius

15 papers receiving 116 citations

Peers

Agnes Bonifacius
John M. Warrington United States
Xuequn Xu United States
Julia Wegner Germany
Xianglei Liu United States
Joshua Gardner United Kingdom
Marinela Kirilova United States
David Ng’ang’a United States
John M. Warrington United States
Agnes Bonifacius
Citations per year, relative to Agnes Bonifacius Agnes Bonifacius (= 1×) peers John M. Warrington

Countries citing papers authored by Agnes Bonifacius

Since Specialization
Citations

This map shows the geographic impact of Agnes Bonifacius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agnes Bonifacius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agnes Bonifacius more than expected).

Fields of papers citing papers by Agnes Bonifacius

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agnes Bonifacius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agnes Bonifacius. The network helps show where Agnes Bonifacius may publish in the future.

Co-authorship network of co-authors of Agnes Bonifacius

This figure shows the co-authorship network connecting the top 25 collaborators of Agnes Bonifacius. A scholar is included among the top collaborators of Agnes Bonifacius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agnes Bonifacius. Agnes Bonifacius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Bonifacius, Agnes, Albert Heim, Rita Beier, et al.. (2025). Transfer of Herpes Simplex Virus Type 1 (HSV-1) Specific T Cells in a Pediatric Patient Post-HSCT With Severe, Acyclovir-resistant HSV-1 Infection. Clinical Infectious Diseases. 82(2). 366–369.
2.
Dragon, Anna Christina, Agnes Bonifacius, Stefan Lienenklaus, et al.. (2025). Depletion of alloreactive B cells by drug-resistant chimeric alloantigen receptor T cells to prevent transplant rejection. Molecular Therapy. 33(3). 1031–1047. 1 indexed citations
3.
Nay, Sandra, Nora Möhn, Lea Grote‐Levi, et al.. (2024). Combined treatment with allogeneic Epstein–Barr- and human polyomavirus 1 specific T-cells in progressive multifocal leukoencephalopathy and EBV infection: a case report. Therapeutic Advances in Neurological Disorders. 17. 4233535005–4233535005.
4.
Bonifacius, Agnes, Anna Christina Dragon, Björn Nashan, et al.. (2024). In Vitro Profiling of Commonly Used Post-transplant Immunosuppressants Reveals Distinct Impact on Antiviral T-cell Immunity Towards CMV. Transplant International. 37. 12720–12720. 1 indexed citations
5.
Kern, Agilo Luitger, Isabell Pink, Agnes Bonifacius, et al.. (2024). Alveolar membrane and capillary function in COVID-19 convalescents: insights from chest MRI. European Radiology. 34(10). 6502–6513. 3 indexed citations
6.
Tischer‐Zimmermann, Sabine, Agnes Bonifacius, Upasana Kulkarni, et al.. (2024). Engineered HCMV‐infected APCs enable the identification of new immunodominant HLA‐restricted epitopes of anti‐HCMV T‐cell immunity. HLA. 103(6). e15541–e15541.
7.
Grote‐Levi, Lea, Nora Möhn, Agnes Bonifacius, et al.. (2023). Adoptive Allogeneic T-Cell Therapy Improves the Clinical Outcome of JC Virus Granule Cell Neuronopathy. Neurology Neuroimmunology & Neuroinflammation. 10(5). 1 indexed citations
8.
Weber, Daniela, Agnes Bonifacius, Britta Eiz‐Vesper, et al.. (2023). Chronic Active Epstein-Barr Virus (EBV) Infection Controlled by Allogeneic Stem Cell Transplantation and EBV-Specific T Cells. Clinical Infectious Diseases. 76(12). 2200–2202. 2 indexed citations
9.
Bonifacius, Agnes, Marius Döring, Ulrich Kalinke, et al.. (2023). Reinforcement of cell-mediated immunity driven by tumor-associated Epstein-Barr virus (EBV)-specific T cells during targeted B-cell therapy with rituximab. Frontiers in Immunology. 14. 878953–878953. 2 indexed citations
11.
Bonifacius, Agnes, Sabine Tischer‐Zimmermann, Lilia Goudeva, et al.. (2022). Antiviral T-Cell Frequencies in a Healthy Population: Reference Values for Evaluating Antiviral Immune Cell Profiles in Immunocompromised Patients. Journal of Clinical Immunology. 42(3). 546–558. 11 indexed citations
12.
Heinrich, S., Agnes Bonifacius, Bastian Engel, et al.. (2022). Reduced humoral but stable cellular SARS-CoV-2-specific immunity in liver transplant recipients in the first year after COVID-19. PLoS ONE. 17(11). e0276929–e0276929. 7 indexed citations
13.
14.
Bonifacius, Agnes, Anne Cossmann, Metodi V. Stankov, et al.. (2021). Long-Lasting Immunity Against SARS-CoV-2: Dream or Reality?. Frontiers in Medicine. 8. 770381–770381. 13 indexed citations
15.
Dragon, Anna Christina, Katharina Zimmermann, Thomas Nerreter, et al.. (2020). CAR-T cells and TRUCKs that recognize an EBNA-3C-derived epitope presented on HLA-B*35 control Epstein-Barr virus-associated lymphoproliferation. Journal for ImmunoTherapy of Cancer. 8(2). e000736–e000736. 38 indexed citations
16.
Bonifacius, Agnes, Oliver Goldmann, Stefan Floess, et al.. (2020). Staphylococcus aureus Alpha-Toxin Limits Type 1 While Fostering Type 3 Immune Responses. Frontiers in Immunology. 11. 16 indexed citations
17.
Bonifacius, Agnes, Joern Pezoldt, Mária Pásztói, et al.. (2018). Yersinia pseudotuberculosis modulates regulatory T cell stability via injection of yersinia outer proteins in a type III secretion system-dependent manner. European Journal of Microbiology and Immunology. 8(4). 101–106. 2 indexed citations
18.
Pásztói, Mária, Agnes Bonifacius, Joern Pezoldt, et al.. (2017). Yersinia pseudotuberculosis supports Th17 differentiation and limits de novo regulatory T cell induction by directly interfering with T cell receptor signaling. Cellular and Molecular Life Sciences. 74(15). 2839–2850. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026